Table 1 Patient and mapping characteristics

Number of patients

57

43

100

Age at exam (in years)

54.0 ± 13.9

(20–83)

54.2 ± 15.7

(19–84)

54.1 ± 14.7

(19–84)

AEDs

 NA

26

27

53

 L

19

11

30

 SA

4

1

5

 NK

5

3

8

 UA

3

1

4

Motor deficit

 ND

41

31

72

 D

16

12

28

Tumor location

 RO

19

16

35

 FR

15

9

24

 PA

11

8

19

 PoG

11

6

17

 TE

1

4

5

Tumor side

 LH

23

17

40

 RH

34

26

60

Dominancy

 NDO

28

25

53

 DO

26

16

42

Edema

 NE

37

31

68

 E

20

12

32

Tumor entity

 II

8

6

14

 III

4

6

10

 IV

21

17

38

 ME

14

11

25

 X

10

3

13

Tumor recurrence

 NR

44

34

78

 R

13

9

22

Tumor volume (in cm³)

27.2 ± 5.4 (19.9–42.9)

26.1 ± 5.0 (20.3–39.9)

26.7 ± 5.2 (19.9–42.9)

rMT (in %)

31.9 ± 7.5 (20–59)

36.4 ± 10.6 (22–72)

33.8 ± 9.3 (20–72)

Year of mapping

 Y10

13

16

29

 Y11

14

6

20

 Y12

10

5

15

 Y13

20

16

36